Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma

Conditions: Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IIID Melanoma Interventions: Biological: LN-144; Drug: Cyclophosphamide; Drug: Mesna; Drug: Fludarabine; Biological: Interleukin-2 (IL-2); Drug: Pembrolizumab Sponsors: James Isaacs, MD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials